Duke Human Vaccine Institute Welcomes Dr. Matthew Kelly as Affiliate Faculty Member
The Duke Human Vaccine Institute (DHVI) is pleased to announce that Matthew Kelly, MD, MPH, has joined DHVI as an affiliate faculty member.
Kevin Saunders, PhD, honored with the 2023 Emerging Leader Award
On Thursday, November 9, 2023, Kevin Saunders, PhD, was honored with the 2023 Emerging Leader Award from the Duke Medical Alumni Association during a special dinner during Medical Alumni Weekend.
Six individuals and one team were honored with Distinguished Awards from the Duke Medical Alumni Association. The special dinner celebration took place at the Washington Duke Inn.
Clinical Immunization Safety Assessment Project Receives Contract from CDC to Continue Vaccine Safety Monitoring
The Duke Human Vaccine Institute (DHVI) successfully recompeted for a five-year, indefinite delivery/indefinite quantity (IDIQ) contract from the Centers for Disease Control and Prevention (CDC) Immunization Safety Office to serve as one of eight medical research centers for the Clinical Immunization Safety Assessment Project (CISA). The contract will allow DHVI to provide services thr
Herman Staats Named as New Duke Human Vaccine Institute Regional Biocontainment Laboratory Leader
The Duke Human Vaccine Institute (DHVI) is pleased to announce the appointment of Herman Staats,PhD, as co-director of the Regional Biocontainment Laboratory (RBL), effective September 1, ahead of becoming the sole director of the RBL, effective January 1, 2024.
DHVI Faculty Appointments - Susanna Naggie
The Duke Human Vaccine Institute (DHVI) is pleased to announce that Susanna Naggie, MD, MHS, has joined DHVI as an affiliate faculty member.
Dr. Chen-Hao Yeh Promoted to Faculty
The Duke Human Vaccine Institute is pleased to announce that Dr. Chen-Hao Yeh has been promoted to the faculty position of Assistant Professor in the Department of Medicine at Duke, effective March 1, 2023.
DHVI Faculty Appointments, Promotion, and Tenure - Dr. Kevin Saunders
The Duke Human Vaccine Institute is pleased to announce that Dr. Kevin O. Saunders has been promoted to Associate Professor in Surgery (tenure) effective July 1, 2022.
DHVI-IVQAC Biorepository Receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute - Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) Biorepository based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. This biorepository accreditation covers the biorepository of Peripheral Blood Mononuclear cells (PBMCs) General Specimen Processing, Long Term Storage, and Distribution.
Duke Human Vaccine Institute to Serve as National Coordinating Center in Fight Against Influenza, COVID-19 and Respiratory Viruses
DHVI receives $4.9 million grant from CDC to serve seven U.S. sites